Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: STRAND THERAPEUTICS INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2025-08-29 to 2027-05-31
Current total value of award: $1249609
Description: SENTINOX (STX)-005: A NEXT-GENERATION THERAPY FOR AUTOIMMUNE DISEASE TO SUSTAIN FORCE READINESS